CN104862332A - Preparation method of protein exposure marker - Google Patents

Preparation method of protein exposure marker Download PDF

Info

Publication number
CN104862332A
CN104862332A CN201510307032.0A CN201510307032A CN104862332A CN 104862332 A CN104862332 A CN 104862332A CN 201510307032 A CN201510307032 A CN 201510307032A CN 104862332 A CN104862332 A CN 104862332A
Authority
CN
China
Prior art keywords
ala
leu
lys
glu
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510307032.0A
Other languages
Chinese (zh)
Inventor
华权高
沈鹤霄
马峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CUSABIO BIOTECH Co Ltd
Original Assignee
CUSABIO BIOTECH Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CUSABIO BIOTECH Co Ltd filed Critical CUSABIO BIOTECH Co Ltd
Priority to CN201510307032.0A priority Critical patent/CN104862332A/en
Publication of CN104862332A publication Critical patent/CN104862332A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a preparation method of a protein exposure marker. The preparation method comprises the steps of selecting expression vectors with different fusion tags according to the molecular weights of required protein exposure markers, carrying out PCR amplification to obtain protein G genes, carrying out enzyme digestion and enzyme link on the protein G genes and the expression vectors with the different fusion tags to obtain expression vectors of different-sized protein G recombinant proteins, converting host cells, carrying out induced expression to obtain the different-sized protein G recombinant proteins, and finally carrying out purification to obtain the protein exposure markers of different molecular weights. By virtue of the preparation method, the prepared protein exposure marker is good in batch repeatability, and the experimental accuracy is guaranteed.

Description

A kind of albumen exposure Marker preparation method
Technical field
The present invention relates to molecular biology and genetically engineered field, especially relate to the preparation method of a kind of albumen exposure Marker.
Background technology
Protein Marker, is often referred to as albumen Marker.In immunoblotting (Western blot) test, though molecular weight of albumen Marker is unremarkable, significant, being positive control, is the standard of size, is necessary.Only have Marker accurately errorless, experimental result is just convincing.In addition, whether albumen Marker can also point out electrophoresis normal, the transfer whether information such as successfully.So select correct albumen Marker to be one of prerequisite of western blot Success in Experiment.
Existing albumen Marker experienced by common Marker, pre-dyed Marker and exposure Marker tri-developmental stage.
Wherein, general proteins Marker, or be referred to as the Protein Marker that is unstained, also premix (pre mixed) molecular weight of albumen Marker is, being the simplest, is also the most a kind of, owing to not attaching dye molecule or tagged molecule, shown size is just in time albumen size originally, is accurately judge albumen size essential product in early days.Common Marker majority all selects the Marker of premix, facilitates the comparison of the albumen of different size.At present, common Marker is handy not as pre-dyed Marker, because can't see completely in electrophoresis process, will wait until that last dyeing could be shown in true appearance together with target protein, cannot play indication with reference to effect to experimentation.Belong to " knowing aftersensation afterwards " type completely, certainly should than " unconsciously " do not do contrast will.
Pre-dyed molecular weight of albumen (prestained Marker), is also pre-dyed Marker, is by Marker albumen, by being coupled with dyestuff covalency, in electrophoresis process or transferring film time can a kind of molecular weight of albumen Marker of arriving of direct visual perception.Pre-dyed Marker brings a lot of convenience, can help us when electrophoresis, after electrophoresis, and monitors electrophoresis situation after transferring film and estimate mobility.Because pre-dyed albumen Marker and dyestuff covalency are coupled, under different buffer conditions, during electrophoresis may there is some change in migrate attribute, may cause some deviations, so be not too applicable to accurate positioning protein.
Common Marker and pre-dyed Marker also has a shortcoming to be exactly develop the color in the film or scanned photograph that can not expose at final Western, final judgement Western result, also need photo and film to compare, be easy to like this cause experimental result to occur deviation or mistake.Exposure Marker (Exposure Marker) is exactly that final Marker band meeting and detection target protein can together appear in the picture of colour developing, avoids occurring deviation when photo and film being compared.Therefore, research and develop high-quality exposure Marker and will provide certain booster action for the progress of scientific experiment.
Summary of the invention
The object of this invention is to provide the preparation method of a kind of albumen exposure Marker.
For achieving the above object, the technical solution used in the present invention is:
The preparation method of a kind of albumen exposure maker, it is characterized in that: select the expression vector with different fusion tag according to desirable proteins exposure marker molecular weight, pcr amplification obtains protein G gene, protein G is cut by enzyme the expression vector that enzyme gets the protein G recombinant protein of different size continuously from the described expression vector with different fusion tag, then transformed host cell, abduction delivering obtains the protein G recombinant protein of different size, obtains the albumen exposure marker of different molecular weight finally by purifying.
Further, described albumen exposure maker molecular weight is between 10-120KD.
Further, the described expression vector with different fusion tag comprises: pET28a, pET32a, pGEX 6P-1 and pMAL-c2x.
Further, described host cell is intestinal bacteria, is preferably e. coli bl21 (DE3).
Further, after obtaining the albumen exposure marker of different molecular weight, detect molecular weight of albumen and purity by SDS-PAGE, and albumen is quantitatively stored.
The application of the albumen exposure maker prepared according to above-mentioned preparation method, needs stripe size needed for albumen exposure Marker, selects the corresponding large small protein after purifying to carry out mixing, packing, namely can be used as the tracing protein of exposure Marker.
The invention provides the preparation method of a kind of albumen exposure Marker, by building the different size fusion tag expression vectors of restructuring containing proteinG, respectively after abduction delivering, purifying, select the protein G recombinant protein of different size as required, then different exposure Marker is prepared after carrying out separation and purification, mixing, between batch, repeatability can ensure completely, ensure that the accuracy of experiment.
Embodiment
The preparation method of the protein fragments of different molecular weight in albumen exposure Marker of the present invention, comprise: select the carrier containing the different fusion tag of band, as prokaryotic expression carriers such as pET28a, pET32a, pGEX 6P-1, pMAL-c2x according to the different sizes of molecular weight of albumen in required exposure Marker; Primer sequence is depending on the design of plasmid and insertion sequence, and cut to lengthen is at about 20bp, and restriction enzyme site is determined according to different plasmids and protein G gene fragment order; By plasmid routine transformation E.Coli BL21DE3 (novagen) respectively built, the protein G recombinant protein of the different size of abduction delivering respectively, then the recombinant protein of escherichia coli expression is carried out purifying by different affinity chromatography methods respectively, can obtain molecular weight be between 10-120KD albumen exposure marker, SDS-PAGE detects molecular weight of albumen and purity, and carries out corresponding condition storage quantitatively, for subsequent use to albumen.
The present invention prepares the protein G fusion rotein of various different size, is mixed in accordance with the appropriate ratio by the protein G fusion rotein of these different sizes, exposure Marker.In WB experiment, exposure Marker and sample carry out SDS-PAGE electrophoresis on same glue, then through transferring film, add antibody incubation, and development, namely can be used as the contrast of experiment.
Preparation method of the present invention can by following specific embodiment detailed description in addition.
Embodiment 1
One, molecular size range is the preparation method of the albumen exposure marker of 10.03kD, 24.19kD, 33.1kD, 49.57kD.
1, synthesize the IgG calmodulin binding domain CaM of streptococcus immune globulin G, the aminoacid sequence in this region is as described in sequence table 5.The nucleotide sequence of the IgG calmodulin binding domain CaM of streptococcus immune globulin G is as described in sequence table 6.This fragment is the IgG binding domains of a molecular weight, all can be in conjunction with the IgG of various common Species origin.And eliminating the interval of other serum proteins combination, its specificity is stronger.
2, following primer is designed, and by the nucleotide sequence in primer amplification sequence table 6.Primer sequence is as follows respectively:
Primer sequence is as follows:
Upstream: CGC gGATCcACCACCTACAA (BamH I)
Downstream: GC gTCGACtTAGGTAACCATT (Sal I)
First by the above-mentioned primer amplification object fragment of method that pcr gene increases, then specific object fragment is reclaimed by SDS-PAGE glue, detect target sequence, then the object fragment increased is reclaimed by separation and purification, obtain object fragment solution, then through and the enzyme of carrier cut and connect process with enzyme and can obtain specific expression vector, for the expression process of recombinant protein.
Expression vector, the restriction enzyme site selected, the characteristic of albumen obtained and the information such as the protein sequence of correspondence and size that the albumen exposure Marker of concrete various different molecular weights is suitable for are as shown in table 1 below.
The albumen exposure Marker of table 1 different molecular weight
By the expression vector transformation of E. coli built, concrete experimental implementation with reference to " molecular cloning handbook ", can carry out the expression of colibacillary cultivation and each specific protein.
Two, molecular size range is the preparation method of the albumen marker of 76.26kD.
Redesign primer with the pGEX 6P-1-protein G obtained for template, increase above-mentioned gained GST-protein G gene, then with the GST-protein G gene insertion pMAL-c2x carrier that Eco R I/sal I will increase for restriction enzyme site.
Wherein primer sequence is as follows:
Upstream: CG gAATTCaTGAGCGATAA (EcoR I)
Downstream: GC gTCGACtTAGGTAACCATT (Sal I)
The recombinant protein characteristic of gained is MBP-GST-protein G, and molecular weight of albumen size is 76.26kD, and the aminoacid sequence of concrete expressed recombinant protein is as shown in sequence table 7.
By the expression vector transformation of E. coli built, concrete experimental implementation with reference to " molecular cloning handbook ", can carry out the expression of colibacillary cultivation and specific protein.
Three, molecular size range is the preparation method of the albumen marker of 111.91kD.
With intestinal bacteria K13 genome for template amplification archaeal dna polymerase 1 gene order (gene order number: 85676195) with NdeI/BamH I for restriction enzyme site inserts in the pet 28a-proteinG plasmid of 1 step gained.
Wherein primer sequence is as follows:
Upstream primer: CGC cATATGgTTCAGATCC
Downstream primer: CGC gGATCcGTGCGCCTGA
Gained recombinant protein characteristic is 6*His-polA-protein G, and the size of molecular weight of albumen is 111.91kD, and the aminoacid sequence of concrete expressed recombinant protein is as shown in sequence table 8.
By the expression vector transformation of E. coli built, concrete experimental implementation with reference to " molecular cloning handbook ", can carry out the expression of colibacillary cultivation and specific protein.
Four, the separation and purification of the albumen of various different molecular weight
Protein specificity is 6*His-protein G, Trx-6*His-protein G, 6*His-polA-proteinG, above three kinds of albumen nickel ion metal chelate chromatography purifying;
Protein specificity is MBP-protein G, MBP-GST-protein G, and above two kinds of albumen are with maltose affinitive layer purification;
Protein specificity is GST-protein G, with gsh affinitive layer purification.
Working method and the flow process of concrete various affinity chromatography column purification can perform with reference to laboratory manual.
Five, the acquisition of albumen exposure marker
The albumen of the different molecular weight after the purifying obtain step 4, according to waiting mole mixing, namely can be used for WB experiment, as using by albumen exposure marker.
It should be noted last that, above embodiment is only in order to illustrate technical scheme of the present invention and unrestricted, although with reference to example to invention has been detailed description, those of ordinary skill in the art is to be understood that, can modify to technical scheme of the present invention or equivalent replacement, and not departing from the spirit and scope of technical solution of the present invention, it all should be encompassed in the middle of right of the present invention.
SEQUENCE LISTING
 
<110> Wuhan Sino-American Biotechnology Company
 
<120> albumen exposure Marker preparation method
 
<130> 2015
 
<160> 8
 
<170> PatentIn version 3.3
 
<210> 1
<211> 93
<212> PRT
<213> artificial sequence
 
<400> 1
 
Met Gly Ser Ser His His His His His His Ser Ser Gly Leu Val Pro
1 5 10 15
 
 
Arg Gly Ser His Met Ala Ser Met Thr Gly Gly Gln Gln Met Gly Arg
20 25 30
 
 
Gly Ser Thr Thr Tyr Lys Leu Val Ile Asn Gly Lys Thr Leu Lys Gly
35 40 45
 
 
Glu Thr Thr Thr Lys Ala Val Asp Ala Glu Thr Ala Glu Lys Ala Phe
50 55 60
 
 
Lys Gln Tyr Ala Asn Asp Asn Gly Val Asp Gly Val Trp Thr Tyr Asp
65 70 75 80
 
 
Asp Ala Thr Lys Thr Phe Thr Val Thr Glu Met Val Thr
85 90
 
 
<210> 2
<211> 224
<212> PRT
<213> artificial sequence
 
<400> 2
 
Met Ser Asp Lys Ile Ile His Leu Thr Asp Asp Ser Phe Asp Thr Asp
1 5 10 15
 
 
Val Leu Lys Ala Asp Gly Ala Ile Leu Val Asp Phe Trp Ala Glu Trp
20 25 30
 
 
Cys Gly Pro Cys Lys Met Ile Ala Pro Ile Leu Asp Glu Ile Ala Asp
35 40 45
 
 
Glu Tyr Gln Gly Lys Leu Thr Val Ala Lys Leu Asn Ile Asp Gln Asn
50 55 60
 
 
Pro Gly Thr Ala Pro Lys Tyr Gly Ile Arg Gly Ile Pro Thr Leu Leu
65 70 75 80
 
 
Leu Phe Lys Asn Gly Glu Val Ala Ala Thr Lys Val Gly Ala Leu Ser
85 90 95
 
 
Lys Gly Gln Leu Lys Glu Phe Leu Asp Ala Asn Leu Ala Gly Ser Gly
100 105 110
 
 
Ser Gly His Met His His His His His His Ser Ser Gly Leu Val Pro
115 120 125
 
 
Arg Gly Ser Gly Met Lys Glu Thr Ala Ala Ala Lys Phe Glu Arg Gln
130 135 140
 
 
His Met Asp Ser Pro Asp Leu Gly Thr Asp Asp Asp Asp Lys Ala Met
145 150 155 160
 
 
Ala Asp Ile Gly Ser Thr Thr Tyr Lys Leu Val Ile Asn Gly Lys Thr
165 170 175
 
 
Leu Lys Gly Glu Thr Thr Thr Lys Ala Val Asp Ala Glu Thr Ala Glu
180 185 190
 
 
Lys Ala Phe Lys Gln Tyr Ala Asn Asp Asn Gly Val Asp Gly Val Trp
195 200 205
 
 
Thr Tyr Asp Asp Ala Thr Lys Thr Phe Thr Val Thr Glu Met Val Thr
210 215 220
 
 
<210> 3
<211> 290
<212> PRT
<213> artificial sequence
 
<400> 3
 
Met Ser Pro Ile Leu Gly Tyr Trp Lys Ile Lys Gly Leu Val Gln Pro
1 5 10 15
 
 
Thr Arg Leu Leu Leu Glu Tyr Leu Glu Glu Lys Tyr Glu Glu His Leu
20 25 30
 
 
Tyr Glu Arg Asp Glu Gly Asp Lys Trp Arg Asn Lys Lys Phe Glu Leu
35 40 45
 
 
Gly Leu Glu Phe Pro Asn Leu Pro Tyr Tyr Ile Asp Gly Asp Val Lys
50 55 60
 
 
Leu Thr Gln Ser Met Ala Ile Ile Arg Tyr Ile Ala Asp Lys His Asn
65 70 75 80
 
 
Met Leu Gly Gly Cys Pro Lys Glu Arg Ala Glu Ile Ser Met Leu Glu
85 90 95
 
 
Gly Ala Val Leu Asp Ile Arg Tyr Gly Val Ser Arg Ile Ala Tyr Ser
100 105 110
 
 
Lys Asp Phe Glu Thr Leu Lys Val Asp Phe Leu Ser Lys Leu Pro Glu
115 120 125
 
 
Met Leu Lys Met Phe Glu Asp Arg Leu Cys His Lys Thr Tyr Leu Asn
130 135 140
 
 
Gly Asp His Val Thr His Pro Asp Phe Met Leu Tyr Asp Ala Leu Asp
145 150 155 160
 
 
Val Val Leu Tyr Met Asp Pro Met Cys Leu Asp Ala Phe Pro Lys Leu
165 170 175
 
 
Val Cys Phe Lys Lys Arg Ile Glu Ala Ile Pro Gln Ile Asp Lys Tyr
180 185 190
 
 
Leu Lys Ser Ser Lys Tyr Ile Ala Trp Pro Leu Gln Gly Trp Gln Ala
195 200 205
 
 
Thr Phe Gly Gly Gly Asp His Pro Pro Lys Ser Asp Leu Glu Val Leu
210 215 220
 
 
Phe Gln Gly Pro Leu Gly Ser Thr Thr Tyr Lys Leu Val Ile Asn Gly
225 230 235 240
 
 
Lys Thr Leu Lys Gly Glu Thr Thr Thr Lys Ala Val Asp Ala Glu Thr
245 250 255
 
 
Ala Glu Lys Ala Phe Lys Gln Tyr Ala Asn Asp Asn Gly Val Asp Gly
260 265 270
 
 
Val Trp Thr Tyr Asp Asp Ala Thr Lys Thr Phe Thr Val Thr Glu Met
275 280 285
 
 
Val Thr
290
 
 
<210> 4
<211> 452
<212> PRT
<213> artificial sequence
 
<400> 4
 
Met Lys Ile Glu Glu Gly Lys Leu Val Ile Trp Ile Asn Gly Asp Lys
1 5 10 15
 
 
Gly Tyr Asn Gly Leu Ala Glu Val Gly Lys Lys Phe Glu Lys Asp Thr
20 25 30
 
 
Gly Ile Lys Val Thr Val Glu His Pro Asp Lys Leu Glu Glu Lys Phe
35 40 45
 
 
Pro Gln Val Ala Ala Thr Gly Asp Gly Pro Asp Ile Ile Phe Trp Ala
50 55 60
 
 
His Asp Arg Phe Gly Gly Tyr Ala Gln Ser Gly Leu Leu Ala Glu Ile
65 70 75 80
 
 
Thr Pro Asp Lys Ala Phe Gln Asp Lys Leu Tyr Pro Phe Thr Trp Asp
85 90 95
 
 
Ala Val Arg Tyr Asn Gly Lys Leu Ile Ala Tyr Pro Ile Ala Val Glu
100 105 110
 
 
Ala Leu Ser Leu Ile Tyr Asn Lys Asp Leu Leu Pro Asn Pro Pro Lys
115 120 125
 
 
Thr Trp Glu Glu Ile Pro Ala Leu Asp Lys Glu Leu Lys Ala Lys Gly
130 135 140
 
 
Lys Ser Ala Leu Met Phe Asn Leu Gln Glu Pro Tyr Phe Thr Trp Pro
145 150 155 160
 
 
Leu Ile Ala Ala Asp Gly Gly Tyr Ala Phe Lys Tyr Glu Asn Gly Lys
165 170 175
 
 
Tyr Asp Ile Lys Asp Val Gly Val Asp Asn Ala Gly Ala Lys Ala Gly
180 185 190
 
 
Leu Thr Phe Leu Val Asp Leu Ile Lys Asn Lys His Met Asn Ala Asp
195 200 205
 
 
Thr Asp Tyr Ser Ile Ala Glu Ala Ala Phe Asn Lys Gly Glu Thr Ala
210 215 220
 
 
Met Thr Ile Asn Gly Pro Trp Ala Trp Ser Asn Ile Asp Thr Ser Lys
225 230 235 240
 
 
Val Asn Tyr Gly Val Thr Val Leu Pro Thr Phe Lys Gly Gln Pro Ser
245 250 255
 
 
Lys Pro Phe Val Gly Val Leu Ser Ala Gly Ile Asn Ala Ala Ser Pro
260 265 270
 
 
Asn Lys Glu Leu Ala Lys Glu Phe Leu Glu Asn Tyr Leu Leu Thr Asp
275 280 285
 
 
Glu Gly Leu Glu Ala Val Asn Lys Asp Lys Pro Leu Gly Ala Val Ala
290 295 300
 
 
Leu Lys Ser Tyr Glu Glu Glu Leu Ala Lys Asp Pro Arg Ile Ala Ala
305 310 315 320
 
 
Thr Met Glu Asn Ala Gln Lys Gly Glu Ile Met Pro Asn Ile Pro Gln
325 330 335
 
 
Met Ser Ala Phe Trp Tyr Ala Val Arg Thr Ala Val Ile Asn Ala Ala
340 345 350
 
 
Ser Gly Arg Gln Thr Val Asp Glu Ala Leu Lys Asp Ala Gln Thr Asn
355 360 365
 
 
Ser Ser Ser Asn Asn Asn Asn Asn Asn Asn Asn Asn Asn Leu Gly Ile
370 375 380
 
 
Glu Gly Arg Ile Ser Glu Phe Gly Ser Thr Thr Tyr Lys Leu Val Ile
385 390 395 400
 
 
Asn Gly Lys Thr Leu Lys Gly Glu Thr Thr Thr Lys Ala Val Asp Ala
405 410 415
 
 
Glu Thr Ala Glu Lys Ala Phe Lys Gln Tyr Ala Asn Asp Asn Gly Val
420 425 430
 
 
Asp Gly Val Trp Thr Tyr Asp Asp Ala Thr Lys Thr Phe Thr Val Thr
435 440 445
 
 
Glu Met Val Thr
450
 
 
<210> 5
<211> 59
<212> PRT
<213> artificial sequence
 
<400> 5
 
Thr Thr Tyr Lys Leu Val Ile Asn Gly Lys Thr Leu Lys Gly Glu Thr
1 5 10 15
 
 
Thr Thr Lys Ala Val Asp Ala Glu Thr Ala Glu Lys Ala Phe Lys Gln
20 25 30
 
 
Tyr Ala Asn Asp Asn Gly Val Asp Gly Val Trp Thr Tyr Asp Asp Ala
35 40 45
 
 
Thr Lys Thr Phe Thr Val Thr Glu Met Val Thr
50 55
 
 
<210> 6
<211> 180
<212> DNA
<213> artificial sequence
 
<400> 6
 
accacctaca aactggttat caacggtaaa accctgaaag gtgaaaccac caccaaagcg 60
 
gttgacgcgg aaaccgcgga aaaagcgttc aaacagtacg cgaacgacaa cggtgttgac 120
 
ggtgtttgga cctacgacga cgcgaccaaa accttcaccg ttaccgaaat ggttacctaa 180
 
<210> 7
<211> 681
<212> PRT
<213> artificial sequence
 
<400> 7
 
Met Lys Ile Glu Glu Gly Lys Leu Val Ile Trp Ile Asn Gly Asp Lys
1 5 10 15
 
 
Gly Tyr Asn Gly Leu Ala Glu Val Gly Lys Lys Phe Glu Lys Asp Thr
20 25 30
 
 
Gly Ile Lys Val Thr Val Glu His Pro Asp Lys Leu Glu Glu Lys Phe
35 40 45
 
 
Pro Gln Val Ala Ala Thr Gly Asp Gly Pro Asp Ile Ile Phe Trp Ala
50 55 60
 
 
His Asp Arg Phe Gly Gly Tyr Ala Gln Ser Gly Leu Leu Ala Glu Ile
65 70 75 80
 
 
Thr Pro Asp Lys Ala Phe Gln Asp Lys Leu Tyr Pro Phe Thr Trp Asp
85 90 95
 
 
Ala Val Arg Tyr Asn Gly Lys Leu Ile Ala Tyr Pro Ile Ala Val Glu
100 105 110
 
 
Ala Leu Ser Leu Ile Tyr Asn Lys Asp Leu Leu Pro Asn Pro Pro Lys
115 120 125
 
 
Thr Trp Glu Glu Ile Pro Ala Leu Asp Lys Glu Leu Lys Ala Lys Gly
130 135 140
 
 
Lys Ser Ala Leu Met Phe Asn Leu Gln Glu Pro Tyr Phe Thr Trp Pro
145 150 155 160
 
 
Leu Ile Ala Ala Asp Gly Gly Tyr Ala Phe Lys Tyr Glu Asn Gly Lys
165 170 175
 
 
Tyr Asp Ile Lys Asp Val Gly Val Asp Asn Ala Gly Ala Lys Ala Gly
180 185 190
 
 
Leu Thr Phe Leu Val Asp Leu Ile Lys Asn Lys His Met Asn Ala Asp
195 200 205
 
 
Thr Asp Tyr Ser Ile Ala Glu Ala Ala Phe Asn Lys Gly Glu Thr Ala
210 215 220
 
 
Met Thr Ile Asn Gly Pro Trp Ala Trp Ser Asn Ile Asp Thr Ser Lys
225 230 235 240
 
 
Val Asn Tyr Gly Val Thr Val Leu Pro Thr Phe Lys Gly Gln Pro Ser
245 250 255
 
 
Lys Pro Phe Val Gly Val Leu Ser Ala Gly Ile Asn Ala Ala Ser Pro
260 265 270
 
 
Asn Lys Glu Leu Ala Lys Glu Phe Leu Glu Asn Tyr Leu Leu Thr Asp
275 280 285
 
 
Glu Gly Leu Glu Ala Val Asn Lys Asp Lys Pro Leu Gly Ala Val Ala
290 295 300
 
 
Leu Lys Ser Tyr Glu Glu Glu Leu Ala Lys Asp Pro Arg Ile Ala Ala
305 310 315 320
 
 
Thr Met Glu Asn Ala Gln Lys Gly Glu Ile Met Pro Asn Ile Pro Gln
325 330 335
 
 
Met Ser Ala Phe Trp Tyr Ala Val Arg Thr Ala Val Ile Asn Ala Ala
340 345 350
 
 
Ser Gly Arg Gln Thr Val Asp Glu Ala Leu Lys Asp Ala Gln Thr Asn
355 360 365
 
 
Ser Ser Ser Asn Asn Asn Asn Asn Asn Asn Asn Asn Asn Leu Gly Ile
370 375 380
 
 
Glu Gly Arg Ile Ser Glu Phe Met Ser Pro Ile Leu Gly Tyr Trp Lys
385 390 395 400
 
 
Ile Lys Gly Leu Val Gln Pro Thr Arg Leu Leu Leu Glu Tyr Leu Glu
405 410 415
 
 
Glu Lys Tyr Glu Glu His Leu Tyr Glu Arg Asp Glu Gly Asp Lys Trp
420 425 430
 
 
Arg Asn Lys Lys Phe Glu Leu Gly Leu Glu Phe Pro Asn Leu Pro Tyr
435 440 445
 
 
Tyr Ile Asp Gly Asp Val Lys Leu Thr Gln Ser Met Ala Ile Ile Arg
450 455 460
 
 
Tyr Ile Ala Asp Lys His Asn Met Leu Gly Gly Cys Pro Lys Glu Arg
465 470 475 480
 
 
Ala Glu Ile Ser Met Leu Glu Gly Ala Val Leu Asp Ile Arg Tyr Gly
485 490 495
 
 
Val Ser Arg Ile Ala Tyr Ser Lys Asp Phe Glu Thr Leu Lys Val Asp
500 505 510
 
 
Phe Leu Ser Lys Leu Pro Glu Met Leu Lys Met Phe Glu Asp Arg Leu
515 520 525
 
 
Cys His Lys Thr Tyr Leu Asn Gly Asp His Val Thr His Pro Asp Phe
530 535 540
 
 
Met Leu Tyr Asp Ala Leu Asp Val Val Leu Tyr Met Asp Pro Met Cys
545 550 555 560
 
 
Leu Asp Ala Phe Pro Lys Leu Val Cys Phe Lys Lys Arg Ile Glu Ala
565 570 575
 
 
Ile Pro Gln Ile Asp Lys Tyr Leu Lys Ser Ser Lys Tyr Ile Ala Trp
580 585 590
 
 
Pro Leu Gln Gly Trp Gln Ala Thr Phe Gly Gly Gly Asp His Pro Pro
595 600 605
 
 
Lys Ser Asp Leu Glu Val Leu Phe Gln Gly Pro Leu Gly Ser Thr Thr
610 615 620
 
 
Tyr Lys Leu Val Ile Asn Gly Lys Thr Leu Lys Gly Glu Thr Thr Thr
625 630 635 640
 
 
Lys Ala Val Asp Ala Glu Thr Ala Glu Lys Ala Phe Lys Gln Tyr Ala
645 650 655
 
 
Asn Asp Asn Gly Val Asp Gly Val Trp Thr Tyr Asp Asp Ala Thr Lys
660 665 670
 
 
Thr Phe Thr Val Thr Glu Met Val Thr
675 680
 
 
<210> 8
<211> 1009
<212> PRT
<213> artificial sequence
 
<400> 8
 
Met Gly Ser Ser His His His His His His Ser Ser Gly Leu Val Pro
1 5 10 15
 
 
Arg Gly Ser His Met Val Gln Ile Pro Gln Asn Pro Leu Ile Leu Val
20 25 30
 
 
Asp Gly Ser Ser Tyr Leu Tyr Arg Ala Tyr His Ala Phe Pro Pro Leu
35 40 45
 
 
Thr Asn Ser Ala Gly Glu Pro Thr Gly Ala Met Tyr Gly Val Leu Asn
50 55 60
 
 
Met Leu Arg Ser Leu Ile Met Gln Tyr Lys Pro Thr His Ala Ala Val
65 70 75 80
 
 
Val Phe Asp Ala Lys Gly Lys Thr Phe Arg Asp Glu Leu Phe Glu His
85 90 95
 
 
Tyr Lys Ser His Arg Pro Pro Met Pro Asp Asp Leu Arg Ala Gln Ile
100 105 110
 
 
Glu Pro Leu His Ala Met Val Lys Ala Met Gly Leu Pro Leu Leu Ala
115 120 125
 
 
Val Ser Gly Val Glu Ala Asp Asp Val Ile Gly Thr Leu Ala Arg Glu
130 135 140
 
 
Ala Glu Lys Ala Gly Arg Pro Val Leu Ile Ser Thr Gly Asp Lys Asp
145 150 155 160
 
 
Met Ala Gln Leu Val Thr Pro Asn Ile Thr Leu Ile Asn Thr Met Thr
165 170 175
 
 
Asn Thr Ile Leu Gly Pro Glu Glu Val Val Asn Lys Tyr Gly Val Pro
180 185 190
 
 
Pro Glu Leu Ile Ile Asp Phe Leu Ala Leu Met Gly Asp Ser Ser Asp
195 200 205
 
 
Asn Ile Pro Gly Val Pro Gly Val Gly Glu Lys Thr Ala Gln Ala Leu
210 215 220
 
 
Leu Gln Gly Leu Gly Gly Leu Asp Thr Leu Tyr Ala Glu Pro Glu Lys
225 230 235 240
 
 
Ile Ala Gly Leu Ser Phe Arg Gly Ala Lys Thr Met Ala Ala Lys Leu
245 250 255
 
 
Glu Gln Asn Lys Glu Val Ala Tyr Leu Ser Tyr Gln Leu Ala Thr Ile
260 265 270
 
 
Lys Thr Asp Val Glu Leu Glu Leu Thr Cys Glu Gln Leu Glu Val Gln
275 280 285
 
 
Gln Pro Ala Ala Glu Glu Leu Leu Gly Leu Phe Lys Lys Tyr Glu Phe
290 295 300
 
 
Lys Arg Trp Thr Ala Asp Val Glu Ala Gly Lys Trp Leu Gln Ala Lys
305 310 315 320
 
 
Gly Ala Lys Pro Ala Ala Lys Pro Gln Glu Thr Ser Val Ala Asp Glu
325 330 335
 
 
Ala Pro Glu Val Thr Ala Thr Val Ile Ser Tyr Asp Asn Tyr Val Thr
340 345 350
 
 
Ile Leu Asp Glu Glu Thr Leu Lys Ala Trp Ile Ala Lys Leu Glu Lys
355 360 365
 
 
Ala Pro Val Phe Ala Phe Asp Thr Glu Thr Asp Ser Leu Asp Asn Ile
370 375 380
 
 
Ser Ala Asn Leu Val Gly Leu Ser Phe Ala Ile Glu Pro Gly Val Ala
385 390 395 400
 
 
Ala Tyr Ile Pro Val Ala His Asp Tyr Leu Asp Ala Pro Asp Gln Ile
405 410 415
 
 
Ser Arg Glu Arg Ala Leu Glu Leu Leu Lys Pro Leu Leu Glu Asp Glu
420 425 430
 
 
Lys Ala Leu Lys Val Gly Gln Asn Leu Lys Tyr Asp Arg Gly Ile Leu
435 440 445
 
 
Ala Asn Tyr Gly Ile Glu Leu Arg Gly Ile Ala Phe Asp Thr Met Leu
450 455 460
 
 
Glu Ser Tyr Ile Leu Asn Ser Val Ala Gly Arg His Asp Met Asp Ser
465 470 475 480
 
 
Leu Ala Glu Arg Trp Leu Lys His Lys Thr Ile Thr Phe Glu Glu Ile
485 490 495
 
 
Ala Gly Lys Gly Lys Asn Gln Leu Thr Phe Asn Gln Ile Ala Leu Glu
500 505 510
 
 
Glu Ala Gly Arg Tyr Ala Ala Glu Asp Ala Asp Val Thr Leu Gln Leu
515 520 525
 
 
His Leu Lys Met Trp Pro Asp Leu Gln Lys His Lys Gly Pro Leu Asn
530 535 540
 
 
Val Phe Glu Asn Ile Glu Met Pro Leu Val Pro Val Leu Ser Arg Ile
545 550 555 560
 
 
Glu Arg Asn Gly Val Lys Ile Asp Pro Lys Val Leu His Asn His Ser
565 570 575
 
 
Glu Glu Leu Thr Leu Arg Leu Ala Glu Leu Glu Lys Lys Ala His Glu
580 585 590
 
 
Ile Ala Gly Glu Glu Phe Asn Leu Ser Ser Thr Lys Gln Leu Gln Thr
595 600 605
 
 
Ile Leu Phe Glu Lys Gln Gly Ile Lys Pro Leu Lys Lys Thr Pro Gly
610 615 620
 
 
Gly Ala Pro Ser Thr Ser Glu Glu Val Leu Glu Glu Leu Ala Leu Asp
625 630 635 640
 
 
Tyr Pro Leu Pro Lys Val Ile Leu Glu Tyr Arg Gly Leu Ala Lys Leu
645 650 655
 
 
Lys Ser Thr Tyr Thr Asp Lys Leu Pro Leu Met Ile Asn Pro Lys Thr
660 665 670
 
 
Gly Arg Val His Thr Ser Tyr His Gln Ala Val Thr Ala Thr Gly Arg
675 680 685
 
 
Leu Ser Ser Thr Asp Pro Asn Leu Gln Asn Ile Pro Val Arg Asn Glu
690 695 700
 
 
Glu Gly Arg Arg Ile Arg Gln Ala Phe Ile Ala Pro Glu Asp Tyr Val
705 710 715 720
 
 
Ile Val Ser Ala Asp Tyr Ser Gln Ile Glu Leu Arg Ile Met Ala His
725 730 735
 
 
Leu Ser Arg Asp Lys Gly Leu Leu Thr Ala Phe Ala Glu Gly Lys Asp
740 745 750
 
 
Ile His Arg Ala Thr Ala Ala Glu Val Phe Gly Leu Pro Leu Glu Thr
755 760 765
 
 
Val Thr Ser Glu Gln Arg Arg Ser Ala Lys Ala Ile Asn Phe Gly Leu
770 775 780
 
 
Ile Tyr Gly Met Ser Ala Phe Gly Leu Ala Arg Gln Leu Asn Ile Pro
785 790 795 800
 
 
Arg Lys Glu Ala Gln Lys Tyr Met Asp Leu Tyr Phe Glu Arg Tyr Pro
805 810 815
 
 
Gly Val Leu Glu Tyr Met Glu Arg Thr Arg Ala Gln Ala Lys Glu Gln
820 825 830
 
 
Gly Tyr Val Glu Thr Leu Asp Gly Arg Arg Leu Tyr Leu Pro Asp Ile
835 840 845
 
 
Lys Ser Ser Asn Gly Ala Arg Arg Ala Ala Ala Glu Arg Ala Ala Ile
850 855 860
 
 
Asn Ala Pro Met Gln Gly Thr Ala Ala Asp Ile Ile Lys Arg Ala Met
865 870 875 880
 
 
Ile Ala Val Asp Ala Trp Leu Gln Ala Glu Gln Pro Arg Val Arg Met
885 890 895
 
 
Ile Met Gln Val His Asp Glu Leu Val Phe Glu Val His Lys Asp Asp
900 905 910
 
 
Val Asp Ala Val Ala Lys Gln Ile His Gln Leu Met Glu Asn Cys Thr
915 920 925
 
 
Arg Leu Asp Val Pro Leu Leu Val Glu Val Gly Ser Gly Glu Asn Trp
930 935 940
 
 
Asp Gln Ala His Gly Ser Thr Thr Tyr Lys Leu Val Ile Asn Gly Lys
945 950 955 960
 
 
Thr Leu Lys Gly Glu Thr Thr Thr Lys Ala Val Asp Ala Glu Thr Ala
965 970 975
 
 
Glu Lys Ala Phe Lys Gln Tyr Ala Asn Asp Asn Gly Val Asp Gly Val
980 985 990
 
 
Trp Thr Tyr Asp Asp Ala Thr Lys Thr Phe Thr Val Thr Glu Met Val
995 1000 1005
 
 
Thr

Claims (6)

1. the preparation method of an albumen exposure maker, it is characterized in that: select the expression vector with different fusion tag according to desirable proteins exposure marker molecular weight, pcr amplification obtains protein G gene, protein G is cut by enzyme the expression vector that enzyme gets the protein G recombinant protein of different size continuously from the described expression vector with different fusion tag, then transformed host cell, abduction delivering obtains the protein G recombinant protein of different size, obtains the albumen exposure marker of different molecular weight finally by purifying.
2. preparation method as claimed in claim 1, is characterized in that: described albumen exposure maker molecular weight is between 10-120KD.
3. preparation method as claimed in claim 1, is characterized in that: the described expression vector with different fusion tag comprises: pET28a, pET32a, pGEX 6P-1 and pMAL-c2x.
4. preparation method as claimed in claim 1, is characterized in that: described host cell is intestinal bacteria.
5. preparation method as claimed in claim 1, is characterized in that: after obtaining the albumen exposure marker of different molecular weight, detect molecular weight of albumen and purity by SDS-PAGE.
6. the albumen prepared according to the preparation method of claim 1 exposes the application of maker, it is characterized in that: stripe size needed for albumen exposure Marker, select the corresponding large small protein after purifying to carry out mixing, packing, namely can be used as the tracing protein of exposure Marker.
CN201510307032.0A 2015-06-05 2015-06-05 Preparation method of protein exposure marker Pending CN104862332A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510307032.0A CN104862332A (en) 2015-06-05 2015-06-05 Preparation method of protein exposure marker

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510307032.0A CN104862332A (en) 2015-06-05 2015-06-05 Preparation method of protein exposure marker

Publications (1)

Publication Number Publication Date
CN104862332A true CN104862332A (en) 2015-08-26

Family

ID=53908508

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510307032.0A Pending CN104862332A (en) 2015-06-05 2015-06-05 Preparation method of protein exposure marker

Country Status (1)

Country Link
CN (1) CN104862332A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107298719A (en) * 2017-08-17 2017-10-27 天德悦(北京)生物科技有限责任公司 Pre-dyed luminescent protein marker preparation method
CN110408639A (en) * 2019-08-01 2019-11-05 天德悦(北京)生物科技有限责任公司 Pre-dyed albumen marker and preparation method thereof, application can be exposed

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101556287A (en) * 2009-02-26 2009-10-14 杭州松华生物科技有限公司 Novel protein molecular weight standard and preparation method thereof
CN102021195A (en) * 2010-10-25 2011-04-20 西北农林科技大学 Method for efficiently preparing protein molecular weight standard by utilizing prokaryotic expression system
CN103923939A (en) * 2014-05-12 2014-07-16 郑州伊美诺生物技术有限公司 Fluorescent protein marker preparation method and application

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101556287A (en) * 2009-02-26 2009-10-14 杭州松华生物科技有限公司 Novel protein molecular weight standard and preparation method thereof
CN102021195A (en) * 2010-10-25 2011-04-20 西北农林科技大学 Method for efficiently preparing protein molecular weight standard by utilizing prokaryotic expression system
CN103923939A (en) * 2014-05-12 2014-07-16 郑州伊美诺生物技术有限公司 Fluorescent protein marker preparation method and application

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"梦纱54": ""蛋白Marker进化史"", 《天涯社区》 *
中公教育医疗卫生系统考试研究院编著: "《医学检验专业知识》", 31 March 2015, 北京:世界图书出版公司 *
何昭阳主编: "《病原细菌检验技术》", 31 July 1992 *
扈荣良主编: "《现代动物病毒学》", 31 December 2014 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107298719A (en) * 2017-08-17 2017-10-27 天德悦(北京)生物科技有限责任公司 Pre-dyed luminescent protein marker preparation method
CN110408639A (en) * 2019-08-01 2019-11-05 天德悦(北京)生物科技有限责任公司 Pre-dyed albumen marker and preparation method thereof, application can be exposed

Similar Documents

Publication Publication Date Title
Kim et al. Complete solubilization and purification of recombinant human growth hormone produced in Escherichia coli
Byrgazov et al. Direct interaction of the N-terminal domain of ribosomal protein S1 with protein S2 in Escherichia coli
CN112111006B (en) Antibody for resisting bovine sarcoidosis virus, detection test paper and kit
CN104862332A (en) Preparation method of protein exposure marker
Nguyen et al. An automated small-scale protein expression and purification screening provides beneficial information for protein production
Sharma et al. Rather rule than exception? How to evaluate the relevance of dual protein targeting to mitochondria and chloroplasts
CN106543272A (en) Multifunctional label fusion protein and its expression and application
Tehseen et al. Proliferating cell nuclear antigen-agarose column: A tag-free and tag-dependent tool for protein purification affinity chromatography
CN110491447A (en) A kind of codon optimization method and application for heterologous gene vivoexpression
CN107383208A (en) Luminescent protein marker preparation method
Fodor et al. Modular broad-host-range expression vectors for single-protein and protein complex purification
Frederick et al. Function and solution structure of the Arabidopsis thaliana RALF8 peptide
CN107298719A (en) Pre-dyed luminescent protein marker preparation method
KR101350355B1 (en) Recombinant plasmid for light-switchable gene expression, transformant and method for controlling gene expression using same
Scopes et al. Analysis of proteins
Plößer et al. A bZIP protein from halophilic archaea: structural features and dimer formation of cGvpE from Halobacterium salinarum
NZ511623A (en) Methods of identifying antigen gene sequences from Mycoplasma
Kim et al. Cell-free synthesis and in situ isolation of recombinant proteins
CN114702559A (en) Bacillus subtilis protein PgsA and application thereof in surface display system
US9458243B2 (en) Secondary antibody detected epitope and preparation of same
CN103014046A (en) Directional cloning method, transformation method of carrier and carrier T
Kohli et al. A Rubredoxin based system for screening of protein expression conditions and on-line monitoring of the purification process
CN105296478A (en) Multi-tag antigen, and preparation method and application thereof
CN106318962B (en) Non-fusion expression vector capable of enhancing target gene expression and preparation method thereof
CN103923939A (en) Fluorescent protein marker preparation method and application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150826